Answers are grounded in this paper and cite their sources.
Case report demonstrates neonatal beta-hCG clearance kinetics and surveillance strategies in an exposed preterm infant, highlighting protocols for early detection of infantile choriocarcinoma.
The birth of a liveborn infant to a mother affected by choriocarcinoma or other forms of gestational trophoblastic disease (GTD) is rare, and guidance for surveillance is limited. Infantile manifestations may include thyroid dysfunction or choriocarcinoma, which can present with cytopenias and metastatic disease to the liver, lungs, or brain—similar to maternal cases. We present a case of an infant born in the third trimester to a mother with metastatic choriocarcinoma, including data on neonatal β-hCG elimination kinetics in a preterm infant and a multidisciplinary surveillance framework for disease monitoring in offspring. This case highlights the need for standardized neonatal monitoring following maternal GTD and demonstrates a multidisciplinary approach for early detection of infantile complications including choriocarcinoma.
No takes yet. Share an insight, caveat, or question.
Klein et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: